Black Rock Inc. Vaxart, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,774,346 shares of VXRT stock, worth $674,251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,774,346
Previous 1,774,346
-0.0%
Holding current value
$674,251
Previous $2.31 Million
48.48%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VXRT
# of Institutions
105Shares Held
23.1MCall Options Held
50.3KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$884,0200.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$670,2750.0% of portfolio
-
State Street Corp Boston, MA851KShares$323,4250.0% of portfolio
-
Ubs Group Ag826KShares$313,7880.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $48.1M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...